Warberg Asset Management »

Portage Biotech shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Portage Biotech (ATON) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Portage Biotech

Tip: Access up to 7 years of quarterly data

All positions including Portage Biotech held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Portage Biotech by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $14k 42k 0.32

More positions owned by Warberg Asset Management

State Str Spdr S&p 500 Etf T Put Put Option
Lumentum Hldgs Note 0.500%12/1 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Microchip Technology Note 1.625% 2/1 (Principal)
Invesco Qqq Tr Put Put Option
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Wisdomtree Note 3.250% 6/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Lci Inds Note 3.000% 3/0 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Cornerstone Strategic Value (CLM)
Txnm Energy Note 5.750% 6/0 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Portage Biotech

Shay Capital
FNY Investment Advisers
One68 Global Capital
Warberg Asset Management
Two Sigma Securities
QTR Family Wealth
Norden Group
Jane Street
UBS Group
BlackRock
Jones Financial Companies, L.L
Morgan Stanley
Royal Bank of Canada
National Bank Of Canada /fi/
Advisor Group Holdings

View all funds holding Portage Biotech